A quick read on this amazing stock... turned over 18% for me in one week.... If you look at the data on this drug and the amazing potential it has to help with diabetics across the world... it seems like a sure thing. The biggest thing with this drug is that it comes in an easy to use inhaler that can be used anywhere at anytime, and acts much like the real human insulin produced by the pancreas. Unlike a needle... which to be honest is not the safest way, even if used properly.
I have done extensive research on this stock and the drug, and analyzed the effect it will have once it hits the market.... trading at a low $3.06 a share right now, watch for a steady rise as more people become aware of this amazing product... at a conference tuesday MannKind released that the FDA is pushing to have product available for children all the way down to 4 years old.